Dexcom(CH:DC4)
CH:DC4
Dexcom ownership
Dexcom (DC4) Ownership - Who Owns Dexcom?
0 Followers
Dexcom (DC4) Ownership Overview
- 0.42% Insiders
- 25.76% Mutual Funds
- 9.40% Other Institutional Investors
- 33.95% ETFs
- 30.47% Public Companies and Individual Investors
The ownership structure of Dexcom (CH:DC4) stock is a mix of institutional, retail, and individual investors. Approximately 69.11% of the company’s stock is owned by Institutional Investors, 0.42% is owned by Insiders, and 30.47% is owned by Public Companies and Individual Investors.
The ownership structure of Dexcom (CH:DC4) stock is a mix of institutional, retail, and individual investors. Approximately 69.11% of the company’s stock is owned by Institutional Investors, 0.42% is owned by Insiders, and 30.47% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 09, 2025 | Jacob Steven Leach | $1,001,579 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | First Eagle Investment Management Llc | CHF3,849 | |
| Dec 31, 2025 | Antipodes Partners Ltd | CHF56,945 | |
| Dec 31, 2025 | Graham Capital Management, L.p. | CHF238,467 | |
| Dec 31, 2025 | Deerfield Management Company, Lp | CHF2,186,426 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 42,777,559 | Institution | 11.47% | ― |
| Vanguard Index Funds | 38,966,352 | Institution | 10.45% | ― |
| BlackRock, Inc. | 38,244,137 | Institution | 10.25% | ― |
| Ishares | 24,416,580 | Institution | 6.55% | ― |
| Invesco | 18,081,391 | Institution | 4.85% | ― |
| Spdr | 15,433,820 | Institution | 4.14% | ― |
| Fidelity Concord Street Trust | 6,951,016 | Institution | 1.86% | ― |
| Vanguard Specialized Funds | 5,384,037 | Institution | 1.44% | ― |
| Amundi | 5,024,236 | Institution | 1.35% | ― |
| Xtrackers | 4,705,449 | Institution | 1.26% | ― |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 38,966,352 | Institution | 10.45% | ― |
| Fidelity Concord Street Trust | 6,951,016 | Institution | 1.86% | ― |
| Vanguard Specialized Funds | 5,384,037 | Institution | 1.44% | ― |
| Fidelity Salem Street Trust | 3,845,884 | Institution | 1.03% | ― |
| Vanguard Institutional Index Funds | 2,280,949 | Institution | 0.61% | ― |
| Mfs Series Trust Iv | 2,198,459 | Institution | 0.59% | ― |
| Tiaa-cref Funds | 2,114,903 | Institution | 0.57% | ― |
| Ab Large Cap Growth Fund Inc | 1,873,549 | Institution | 0.50% | ― |
| Ivy Funds | 1,613,191 | Institution | 0.43% | ― |
| Franklin Strategic Series | 1,556,539 | Institution | 0.42% | ― |
FAQ
Who Owns Dexcom (CH:DC4)?
According to the latest TipRanks data, approximately 69.11% of the company's stock is held by institutional investors, 0.42% is held by insiders, and 30.47% is held by public companies and individual investors.
What percentage of Dexcom (CH:DC4) stock is held by institutional investors?
According to the latest TipRanks data, approximately 69.11% of Dexcom (CH:DC4) stock is held by institutional investors: 25.76% by mutual funds, 33.95% by ETFs and 9.40% by other institutional investors.
What percentage of Dexcom (CH:DC4) stock is held by retail investors?
According to the latest TipRanks data, approximately 30.47% of Dexcom (CH:DC4) stock is held by public companies and individual investors.
Who owns the most shares of Dexcom (CH:DC4)?
Vanguard owns the most shares of Dexcom (CH:DC4).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
